YTHDF2 and non-small cell lung carcinoma: Interestingly, high expression of YTHDF1 and YTHDF2 was associated with a better prognosis in 603 cases of resected NSCLC, which might be due to increased tumor-infiltrating lymphocytes (TILs) and decreased co-inhibitor molecule PD-L1 (226).